Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas
Neuro-Oncology · 2024
DOI: 10.1093/neuonc/noad228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Nathalie L Albert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, LMU Hospital, LMU Munich, Munich, Germany.
- Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Nathalie L Albert, Matthias Preusser
Zitieren
APA
Albert, N. L., & Preusser, M. (2024). Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/noad228
Vancouver
Albert NL, Preusser M. Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas. Neuro-Oncology. 2024. doi:10.1093/neuonc/noad228
BibTeX
@article{Albert2024,
author = {Albert, Nathalie L and Preusser, Matthias},
title = {Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomas},
journal = {Neuro-Oncology},
year = {2024},
doi = {10.1093/neuonc/noad228}
}
EUVIMED